Cytox Limited, a UK company developing diagnostic and prognostic services for neurodegenerative diseases such as Alzheimer’s disease, has signed up to the Compliance Control Centre Electronic Quality and Document Management System.
Cytox is currently setting up a laboratory in Manchester to provide its phenoTOR™ assay for investigational use in the evaluation of new drugs targeted at dementia and Alzheimer’s disease. This service should enable patient stratification to enhance drug discovery and efficacy trials by means of a simple blood test.
ComplianceControl Centre has recently launched a new version of its electronic Document and Quality Management System, that will be used to cover all aspects of Cytox’s Quality and Compliance Management system, including ISO 13485. The system will manage documentation, equipment, training records, audits, and corrective actions and preventative actions, to ensure proactive compliance management and will be particularly useful providing visibility of compliance across all the Cytox offices and laboratories.
Dr Richard Pither CEO, explained: “As we are now moving into the commercial phase of our business plan we needed to ensure that all our processes and data handling were compliant with European and USA regulations. This is particularly important for our laboratory service accreditation and our longer term clinical trials programmes.
We are a small company working in several locations and we wanted a simple, cost effective, and validated solution for a price that we could afford. The CCC “out of the box” solution allowed us to move quickly to a working system and we are very pleased with the service and support we have received from the company to date”
David Forrest, Chief Executive of Compliance Control Ltd. stated: We are pleased with the latest release of our software, which has been developed with help from the Technology Strategy Board Grant awarded in 2012 and funding from the Northwest Biomedical Fund. The new Software as a Service release really does mean that SME’s can now have access to Quality and Compliance software traditionally only available to larger organisations at an affordable price applicable to many small startup and growing companies”.
Forrest continued: “Cytox wanted a system that could be available and validated immediately, so that they could spend time using the system, not designing, customising and validating it. ComplianceControl Centre is an ‘Off the Shelf’ (GAMP®5 Category 3) product, which means that the system can be operational and fully validated within five days.”
Compliance Control Ltd.
ComplianceControl Centre, is a Software as a Service (SaaS) electronic Quality and Document Management Software System that provides real-time visibility of the complete Quality, Compliance and Validation status of an organization.
Compliance Control Ltd. provide Compliance, Validation and Quality Consultancy Services and Products to the life science and pharmaceutical globalmarkets. Services include Compliance and Validation planning and strategy, Documentation and Testing, along with a series of Auditing services and Computer System Validation Training courses.
Click Here for original source